Program and grad year: BSc(Pharm)’85, MSc’87, PhD’92
Career: Vice President DMPK, Arcus Biosciences
"Reflecting on his path, Matt emphasizes that careers are rarely linear, and being open to new opportunities can lead to experiences far beyond what was originally planned."
Matt Wright, UBC Faculty of Pharmaceutical Sciences alumnus (BSc(Pharm)’85, MSc’87, PhD’92), has built a dynamic career that spans academia, startups, and global pharmaceutical companies. After beginning in academia, he transitioned into industry, taking on roles at organizations including DuPont Merck, Tularik, Gilead, Genentech, and Arcus Biosciences. Across these experiences, Matt has held leadership positions in drug discovery and development, with a career shaped by curiosity, adaptability, and a willingness to pursue new opportunities as they arise.
From academia to industry: Embracing the unexpected
Matt began his career with a clear intention to stay in academia, completing his graduate training before stepping into a faculty role. However, a combination of personal and professional factors led him to explore industry, starting with DuPont Merck and eventually moving into biotech and large pharmaceutical companies. Reflecting on his path, Matt emphasizes that careers are rarely linear, and being open to new opportunities can lead to experiences far beyond what was originally planned.
Why your first industry role matters
One of Matt’s strongest pieces of advice for emerging alumni is to be intentional about their first role in industry. He highlights the importance of starting in an established organization where strong processes, mentorship, and scale provide a solid foundation. While startups offer excitement and responsibility, larger companies can provide critical early-career learning that shapes long-term success.
The power of mentorship and staying connected
Throughout his career, Matt has seen firsthand the impact of mentorship and professional networks. He encourages alumni to actively seek out mentors and build connections within the industry, noting that the biotech and pharmaceutical community is smaller than it seems. Over time, Matt has also found renewed value in reconnecting with UBC through student mentorship and faculty collaboration, reinforcing the importance of staying engaged with the alumni community.